The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Recurrence and survival outcomes following adjuvant therapy for early-stage uterine serous carcinoma (USC).
David A. Iglesias
No relevant relationships to disclose
Laura L. Holman
No relevant relationships to disclose
Shannon Neville Westin
No relevant relationships to disclose
Bryan Fellman
No relevant relationships to disclose
Kathleen M. Schmeler
No relevant relationships to disclose
Pedro T Ramirez
No relevant relationships to disclose
Michael M. Frumovitz
No relevant relationships to disclose
Karen H. Lu
No relevant relationships to disclose
Pamela T. Soliman
No relevant relationships to disclose